SI-BONE, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
SI-BONE, INC. (SIBN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$14.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-24
- SI-BONE, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was -$14.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | -$14.00K 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |